Skip to main content
Medical

Testicular Mesothelioma

Also known as: Mesothelioma of the tunica vaginalis testis, Paratesticular mesothelioma, Mesothelioma of the tunica vaginalis

Paul Danziger Legally reviewed by Paul Danziger, J.D. · Medical content verified against NCI, ACS & peer-reviewed research · · Editorial Policy
On This Page

What is Testicular Mesothelioma?

Testicular mesothelioma is the rarest form of malignant mesothelioma, arising from the tunica vaginalis — the membranous lining that surrounds each testicle. Fewer than 100 cases have been documented in the global medical literature, making it an exceptionally uncommon malignancy that accounts for less than 1% of all mesothelioma diagnoses.1

Because of its extreme rarity, testicular mesothelioma is frequently discovered incidentally during surgical procedures for other conditions, most commonly hydrocelectomy (surgical repair of a hydrocele) or inguinal hernia repair. Patients typically present with a painless scrotal mass or swelling that mimics more common conditions such as hydrocele, epididymal cyst, or testicular torsion. This often leads to significant diagnostic delays.2

The relationship between asbestos exposure and testicular mesothelioma is less clearly established than for pleural or peritoneal mesothelioma. Approximately 30–40% of reported cases have a documented history of occupational asbestos exposure, though the mechanism by which inhaled or ingested asbestos fibers reach the tunica vaginalis remains uncertain.3 Proposed pathways include hematogenous or lymphatic transport of fibers from the lungs or peritoneum.

Due to the small number of cases, there is no standardized treatment protocol. Radical inguinal orchiectomy remains the primary surgical approach, and adjuvant chemotherapy or radiation may be considered depending on the extent of disease. Recurrence rates are high — estimated at 50–60% — and long-term surveillance is essential following initial treatment.4

Key Facts
Prevalence Fewer than 100 cases reported in medical literature
Percentage of all mesothelioma Less than 1%
Primary site Tunica vaginalis testis
Median age at diagnosis 55–60 years
Asbestos link confirmed Approximately 30–40% of cases
Primary treatment Radical inguinal orchiectomy

What are the types of testicular mesothelioma?

Testicular mesothelioma originates exclusively in the tunica vaginalis testis and does not have formally recognized subtypes based on anatomic location. However, like all mesotheliomas, it is classified by histological cell type:

  • Epithelioid — the most commonly reported cell type in testicular cases, generally carrying a more favorable prognosis
  • Biphasic — containing both epithelioid and sarcomatoid components
  • Sarcomatoid — rare in testicular mesothelioma and associated with poorer outcomes

What are the symptoms of testicular mesothelioma?

Symptoms of testicular mesothelioma are often nonspecific and may be mistaken for more common scrotal conditions:

  • Painless scrotal mass or swelling
  • Hydrocele (fluid accumulation around the testicle)
  • Scrotal heaviness or discomfort
  • Inguinal swelling that may suggest hernia
  • Testicular enlargement without pain
  • Rarely, acute scrotal pain if torsion or hemorrhage occurs

Many cases are entirely asymptomatic and are discovered only during surgery for suspected benign conditions.

What causes testicular mesothelioma?

Asbestos exposure has been documented in approximately 30–40% of testicular mesothelioma cases, though a definitive causal link is more difficult to establish than for pleural mesothelioma due to the small number of cases. The precise mechanism by which asbestos fibers reach the tunica vaginalis is not fully understood. Proposed pathways include:

  • Lymphatic transport of fibers from the peritoneal cavity through the processus vaginalis
  • Hematogenous (blood-borne) dissemination of fibers
  • Translocation from the peritoneum via the inguinal canal

In many reported cases, no asbestos exposure history can be identified, suggesting other unknown etiologic factors may contribute.

What are the risk factors for testicular mesothelioma?

Due to the extreme rarity of testicular mesothelioma, risk factors are not as well characterized as for other forms. Known and suspected risk factors include:

  • Occupational asbestos exposure — shipyard work, construction, insulation installation, automotive brake repair
  • Secondary asbestos exposure — living with an asbestos worker (take-home exposure)
  • Age — most cases diagnosed between ages 55 and 75
  • Prior hydrocele or hernia — some cases present alongside these conditions, though it is unclear if they represent true risk factors or incidental findings

How is testicular mesothelioma diagnosed?

Diagnosing testicular mesothelioma is challenging because the condition is rarely suspected before surgery. The diagnostic process typically involves:

  • Physical examination — palpation of a scrotal mass or detection of hydrocele
  • Scrotal ultrasound — may reveal a solid mass or complex fluid collection, but findings are nonspecific
  • CT or MRI — used to evaluate extent of disease and rule out metastasis
  • Surgical exploration — most cases are diagnosed at the time of surgery for suspected benign conditions
  • Histopathological examination — definitive diagnosis requires tissue biopsy with immunohistochemical staining (calretinin, WT1, CK5/6 positive; CEA, MOC-31 negative)

Immunohistochemistry is essential to distinguish mesothelioma from adenocarcinoma, reactive mesothelial hyperplasia, and other testicular or paratesticular tumors.

How is testicular mesothelioma treated?

There is no standardized treatment protocol for testicular mesothelioma due to its rarity. Current management is guided by case reports and small case series:

  • Radical inguinal orchiectomy — the primary surgical treatment, removing the affected testicle through an inguinal incision (not a scrotal approach, to reduce the risk of local seeding)
  • Hemiscrotectomy — may be performed if the tumor has invaded the scrotal wall
  • Retroperitoneal lymph node dissection — considered in cases with suspected or confirmed nodal involvement
  • Adjuvant chemotherapy — cisplatin-based regimens (typically cisplatin and pemetrexed) may be offered, though evidence for efficacy is limited
  • Radiation therapy — occasionally used as adjuvant treatment, though its role remains unclear

Given the high recurrence rate of 50–60%, close long-term surveillance with serial imaging and physical examination is strongly recommended following initial treatment.4

What is the prognosis for testicular mesothelioma?

The prognosis for testicular mesothelioma is variable and difficult to characterize due to the limited number of cases. Key prognostic considerations include:

  • Median survival is estimated at 20–24 months, though some patients have survived more than 5 years after diagnosis
  • Recurrence rates are high, estimated at 50–60% of cases
  • Epithelioid histology is associated with better outcomes compared to sarcomatoid or biphasic subtypes
  • Early-stage disease confined to the tunica vaginalis carries a more favorable prognosis than cases with lymph node or distant metastasis
  • Complete surgical resection with negative margins is the strongest positive prognostic factor

Can testicular mesothelioma be prevented?

Because the link between asbestos exposure and testicular mesothelioma is not as firmly established as for other types, specific prevention guidelines are limited. General recommendations include:

  • Avoiding occupational and environmental asbestos exposure
  • Following OSHA regulations for asbestos handling and abatement
  • Using appropriate personal protective equipment (PPE) in at-risk occupations
  • Seeking medical evaluation for unexplained scrotal swelling, especially in individuals with a history of asbestos exposure

Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider.

Frequently Asked Questions

How rare is testicular mesothelioma?

Testicular mesothelioma is the rarest form of mesothelioma, with fewer than 100 cases reported in the global medical literature. It accounts for less than 1% of all mesothelioma diagnoses.

Is testicular mesothelioma caused by asbestos?

Approximately 30–40% of documented cases have a confirmed history of asbestos exposure. However, the causal relationship is less clearly established than for pleural or peritoneal mesothelioma, and many cases occur without a known exposure history.

How is testicular mesothelioma different from testicular cancer?

Testicular mesothelioma arises from the tunica vaginalis (the lining around the testicle), not from the testicular tissue itself. Standard testicular cancers — such as seminoma and nonseminoma — originate from germ cells within the testicle and have different treatment protocols and prognoses.

What is the survival rate for testicular mesothelioma?

Median survival is estimated at 20–24 months, though outcomes vary widely. Some patients with early-stage disease and complete surgical resection have survived more than 5 years. The high recurrence rate of 50–60% underscores the importance of long-term follow-up.

Can I file a legal claim for testicular mesothelioma caused by asbestos?

Yes. If your testicular mesothelioma is linked to asbestos exposure — whether occupational, secondary, or environmental — you may be eligible to file a legal claim for compensation. This can include lawsuits against asbestos manufacturers, trust fund claims, and VA benefits for veterans. An experienced mesothelioma attorney can evaluate your exposure history and advise you on your legal options.

Call Now: (800) 400-1805 Free Case Review • Available 24/7